Key result
PD-1 blockade alters plaque immune phenotypes, implicating IFNγ-producing T cells in heightened cardiovascular risk.
Why the study?
Does PD-1 blockade alter plaque immune phenotype and T cell accumulation in murine atherosclerotic models?
Does PD-1 blockade alter plaque immune phenotype and T cell accumulation in murine atherosclerotic models?
Answers are grounded in this paper and cite their sources.
Progenitor exhausted PD-1+ T cells produce IFNγ and are identified as a potential key immune cell population mediating the increased cardiovascular risk associated with immune checkpoint inhibitors.
Immune checkpoint inhibitors (ICIs), targeting checkpoint receptors such as programmed cell death protein 1 (PD-1), are associated with increased risk of cardiovascular events, but the underlying mechanisms remain poorly understood. Here we show that PD-1 + T cells from murine atherosclerotic aortas mainly display a progenitor exhausted phenotype (PD-1 int Slamf6 + Tim3 − ), produce IFNγ in vivo, exhibit signs of recent proliferation and maintain polyfunctionality. PD-1 blockade induced marked changes in plaque immune phenotype, with increased PD-1 high T cell accumulation, IFNγ production, formation of lymphocyte foci and neutrophil recruitment. Depletion of PD-1 high T cells prior to PD-1 blockade did not impede T cell recruitment, suggesting a role for progenitor exhausted PD-1 int T cells in ICI-driven T cell plaque accumulation. Human circulating PD-1 + T cells produced IFNγ and were associated with subclinical coronary atherosclerosis. Our studies highlight IFNγ-producing PD-1 + T cells as a potential key immune cell population mediating increased cardiovascular risk in patients with cancer receiving ICI.
No takes yet. Share an insight, caveat, or question.
Mulholland et al. (2025) studied Atherosclerosis. PD-1 blockade was evaluated on Plaque immune phenotype and T cell accumulation. PD-1 blockade induced marked changes in plaque immune phenotype, highlighting IFNγ-producing PD-1+ T cells as a potential key population mediating increased cardiovascular risk from immune checkpoint inhibitors.
Synapse has enriched 10 related papers. Consider them for comparative context: